|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
| City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | Chicago |
State | IL |
Zip Code | 60611-5885 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
||||||||
| TYPE OF REPORT | 8. Year | 2015 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: George E. Cox III, JD |
Date | 1/20/2016 12:49:04 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 2029, Consolidated Appropriations Act, 2016, provisions relating to Meaningful Use and Conrad 30 J-1 Visa program Reauthorization
H.R. 1314, Bipartisan Budget Act of 2015, provisions relating to health care
S. 2170, Veterans E-Health & Telemedicine Support (VETS) Act of 2015, all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Eileen |
Carlson |
|
|
|
Debra |
Cohn |
|
|
|
Charles |
Kels |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Higher Education Reauthorization
Graduate Medical Education
Public Service Loan Forgiveness
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Education - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Thomas |
Roberge |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Kristen |
O'Brien |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 3537, Synthetic Drug Control Act of 2015, all provisions
H.R. 3940, Meaningful Use Hardship Relief Act of 2015, all provisions
H.R. 1270, Restoring Access to Medication Act of 2015, all provisions
S. 709, Restoring Access to Medication Act of 2015, all provisions
H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015, all provisions
H.R. 3309, Flex-IT 2 Act, all provisions
S. 2141, Transparent Ratings on Usability and Security to Transform Information Technology (TRUST IT) Act of 2015, all provisions
H.R. 3520, Pulmonary Hypertension Research and Diagnosis Act of 2015, all provisions
H.R. 1936, Improving the Integrity of Disability Evidence Act, all provisions
S. 1945, Mental Health Reform Act of 2015, all provisions
H.R. 2646, Helping Families in Mental Health Crisis Act of 2015, all provisions
H.R. 293, To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes, all provisions
H.R.6, 21st Century Cures Act, all provisions
H.R. 3680, Co-Prescribing to Reduce Overdoses Act of 2015, all provisions
H.R. 3770, End Surprise Billing Act of 2015, all provisions
Radiation Oncology Therapy Coding
Medical Licensure - The Interstate Medical Licensure Compact
Prescription Drug Diversion and Abuse
Physician Owned Hospitals
Health Savings Accounts - Prescription requirements for over-the-counter medications
Opioid Abuse
Telemedicine
Drug Pricing
Electronic Health Records (EHR) interoperability and certification
Meaningful Use/hardship exemptions and Stage 3 regulations
Precision Medicine
Cybersecurity
Sunshine Act
FDA/NIH Modernization
Laboratory Developed Tests (LDT)
Mental health and HIPAA privacy law
HIPAA
Chronic care
Child-resistant packaging for energy drinks
COBRA grace period
Dietary guidelines
ICD-10
Antibiotic resistance
Pre-diabetes
Hypertension
Homelessness - impact on health
XR-29-2013 related penalty/12 month delay
Clinical Laboratory Improvement Amendments (CLIA)/oversight modernization
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Office of Natl Drug Control Policy (NDCP), Health & Human Services - Dept of (HHS), Office of Science & Technology Policy (OSTP), Food & Drug Administration (FDA), Labor - Dept of (DOL), Housing & Urban Development - Dept of (HUD), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Sandy |
Marks |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Eileen |
Carlson |
|
|
|
Debra |
Cohn |
|
|
|
Charles |
Kels |
|
|
|
Kristen |
O'Brien |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
H.R. 2131, Supplying Knowledge-based Immigrants and Lifting Levels of STEM Visas Act (SKILLS Visa Act), all provisions
H.R. 4234, Primary Care Physician Reentry Act of 2015, all provisions
S.1189, Conrad State 30 and Physician Access Act, all provisions
Insurance Industry Consolidation
Telehealth and Licensure
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Justice - Dept of (DOJ)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
George |
Cox |
III |
|
|
Charles |
Kels |
|
|
|
Kristen |
O'Brien |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015, all provisions
S. 141, Protecting Seniors' Access to Medicare Act of 2015, all provisions
H.R. 2102, Medicare Diabetes Prevention Act of 2015, all provisions
S. 1131, Medicare Diabetes Prevention Act of 2015, all provisions
H.R. 169, Critical Access Hospital Relief Act of 2015, all provisions
S. 258, Critical Access Hospital Relief Act of 2015, all provisions
H.R. 2513, Promoting Access, Competition, and Equity (PACE) Act of 2015, all provisions
S. 2153, Provider Payment Sunshine Act, all provisions
S. 2425, Patient Access and Medicare Protection Act, all provisions
H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015, all provisions
H.R. 3309, Flex-IT 2 Act, all provisions
H.R. 976, Patient Access to Higher Quality Health Care Act of 2015, all provisions
H.R. 1018, Patient Access to Disposable Medical Technology Act of 2015, all provisions
H.R. 2568, Fair Medical Audits Act of 2015, all provisions
H.R. 169, Critical Access Hospital Relief Act of 2015, all provisions
H.R. 3940, Meaningful Use Hardship Relief Act of 2015, all provisions
S. 2141, Transparent Ratings on Usability and Security to Transform Information Technology (TRUST IT) Act of 2015, all provisions
S. 2368, Audit & Appeals Fairness, Integrity, and Reforms in Medicare Act of 2015, all provisions
H.R. 1470, SGR Repeal and Medicare Provider Payment Modernization Act of 2015, all provisions
S. 810, SGR Repeal and Medicare Provider Payment Modernization Act of 2015, all provisions
H. R.2 - Medicare Access and CHIP Reauthorization Act of 2015, all provisions
S. 843, Improving Access to Medicare Coverage Act of 2015, all provisions
H.R. 3770, End Surprise Billing Act of 2015, all provisions
Medicare program: Protecting Access to Medicare Act (PAMA) implementation
Medicare program: MACRA Implementation/Alternate payment models
Medicare program: ACA implementation/Marketplace open enrollment
Medicare program: Independent Payment Advisory Board Repeal (IPAB)
Medicare program: Misvalued Codes
Medicare program: Meaningful Use Regulations/Electronic Health Records
Medicare program: Electronic Health Records (EHR) interoperability and certification
Medicare program: Telehealth and Medicare coverage
Medicare program: Sequestration
Medicare program: Comprehensive Joint Replacement Initiative
Medicare program: In-Office Ancillary Services Exception (IOASE)
Medicare program: Merit-Based Incentive Payment System (MIPS)
Medicare program: Value-Based Payment Modifier (VPM)
Medicare program: Graduate Medical Education (GME)
Medicare program: Meaningful Use/hardship exemptions and Stage 3 regulations
Medicare program: Prescription Drug Diversion
Medicare program: Physician data
Medicare program: Clinical Diagnostic Laboratory Tests Payment System
Medicare program: Physician Quality Reporting System (PQRS)
Medicare program: Drugs of Abuse Testing
Medicare program: Program Integrity
Medicare program: Recovery Audit Contracting (RAC)
Medicare program: Mental health and HIPAA privacy law
Medicare program: Chronic care
Medicare program: Medicare Advantage/narrow networks
Medicare program: Pre-diabetes
Medicare program: Hypertension
Medicare program: Drug pricing
Medicare program: Relative Value Scale Update Committee (RUC)
Medicaid program: Medicaid expansion
Medicaid program: CPT
Medicare and Medicaid programs: ICD-10
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), White House Office, Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Jason |
Scull |
III |
|
|
George |
Cox |
|
|
|
Eileen |
Carlson |
|
|
|
Debra |
Cohn |
|
|
|
Charles |
Kels |
|
|
|
Kristen |
O'Brien |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Tobacco cessation
17. House(s) of Congress and Federal agencies Check if None
Health & Human Services - Dept of (HHS), Labor - Dept of (DOL), Treasury - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R. 865, Good Samaritan Health Professionals Act of 2015, all provisions
H.R. 4234, Primary Care Physician Reentry Act of 2015, all provisions
H.R. 921, Sports Medicine Licensure Clarity Act of 2015, all provisions
Sports Medicine Liability
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Charles |
Kels |
|
|
|
Kristen |
O'Brien |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
S. 2170, Veterans E-Health & Telemedicine Support (VETS) Act of 2015, all provisions
H.R. 1604, Veterans' Mental Health Care Access Act, all provisions
VA Choice Program
Veterans Administration
Scope of Practice
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Thomas |
Roberge |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
S. 544, Secret Science Reform Act of 2015, all provisions
H.R. 3483, Stop Nuclear Waste by Our Lakes Act of 2015, all provisions
S. 2026, Stop Nuclear Waste by Our Lakes Act of 2015, all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Thomas |
Roberge |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AVI
16. Specific lobbying issues
S. 571, Pilot's Bill of Rights 2, all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Thomas |
Roberge |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |